Biocon Announces ₹11,450-Crore Capital Plan to Drive Biologics Integration
New Delhi, Dec 06 : Biocon Ltd has announced a comprehensive capital plan worth ₹11,450 crore to accelerate the integration of its biologics operations and strengthen its position as a global biopharmaceutical leader. The strategic initiative is aimed at consolidating manufacturing, enhancing supply chain efficiency, and enabling long-term growth…
Read More...